Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
bimatoprost (lumigan) (1 trial)
dorzolamide (trusopt) (1 trial)
timolol (blocadren) (1 trial)
Glaucoma, Open-Angle (Phase 4)
Trials (1 total)
Trial APIs (3 total)